🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-centre, randomised, double-blind, placebo-controlled ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-10-01
Trial ID
NCT02567708
Treatments Being Tested
The study will be a double-blind, randomized, placebo-controlled, single-ce...
Status
Unknown
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00176020
Treatments Being Tested
GW870086X is a novel inhaled steroid that has an improved safety profile ov...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09
Trial ID
NCT00549497
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, 4-week intervention...
Status
Completed
Location
Applied Science and Performance Institute
Start Date
2024-02-21
Trial ID
NCT06309914
A clinical trial to investigate the safety and tolerability of single and m...
Status
Recruiting
Location
Bulgaria MC Comac Medical Ltd.
Start Date
2025-09-15
Trial ID
NCT07163182
Treatments Being Tested
The purpose of this trial is primarily to investigate the safety and tolera...
Status
Completed
Location
Nycomed Investigational Site
Start Date
2011-03
Trial ID
NCT01317797
Treatments Being Tested
Investigate whether ranolazine, a novel anti-anginal agent with antiarrhyth...
Status
Unknown
Location
Walter Reed National Military Medical Center
Start Date
2014-01
Trial ID
NCT01996618
Treatments Being Tested
This study is designed to evaluate repeat doses of isavuconazole on cardiac...
Status
Completed
Location
Parexel
Start Date
2012-03
Trial ID
NCT01565720
Treatments Being Tested
The purpose of the study is to evaluate if AZD3480 and warfarin interact wi...
Status
Completed
Location
Research Site
Start Date
2008-03
Trial ID
NCT00689559
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Terminated
Location
Richmond Pharmacology Ltd.
Start Date
2013-12
Trial ID
NCT02083666